CBT
28
8
8
11
Key Insights
Highlights
Success Rate
79% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
10.7%
3 terminated out of 28 trials
78.6%
-7.9% vs benchmark
0%
0 trials in Phase 3/4
36%
4 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (28)
Sleep IntervEntion as Symptom Treatment for ADHD
The Effect of Self Stigma Tailored Cognitive Behavioral Therapy on Gambling Disorder
Adaptation of the ECCCLORE Program for Patients With Addictive and Traumatic Problems
Blended Treatment för PTSD: A New Format of Computer-Assisted Trauma-Focused Cognitive Behavioral Therapy
Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease
Adapting The Fear Of Recurrence Therapy (FORT) for Parents and Establishing Acceptability and Feasibility
Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity
A Hybrid Type 2 Trial of Trauma-Focused Cognitive Behavioral Therapy and a Pragmatic Individual-Level Implementation Strategy
Mindfulness and Compassive Acceptance for Chronic Insomnia in Comparison With CBT
SGM Evidenced-Based Mental Healthcare Implementation
Pain and Weight Treatment: Development and Trial of PAW
CBT and the Neural Circuits of Anxiety
Brief Cognitive Behaviour Therapy (CBT) for Adolescent OCD in Routine Clinical Practice
Optimizing CBT Implementation Among Community Providers Through Internet-based Consultation and Networking (i-CAN)
Feasibility, Acceptability and Effect of a Transdiagnostic Psychological Treatment for Anxiety and Depression in Youth.
GIST and Memory and Attention Adaptation Training
It's Time to Address Fear of Cancer Recurrence in Family Caregivers: Online Version of the Fear Of Recurrence Therapy
Effects of CBT-Based Intervention Among Patients With Liver Cancer
Study on the Remote Diagnosis and Treatment Strategy of New-onset Insomnia Under the COVID-19 Epidemic
Effects of Cognitive Behavior Therapy on Quality of Life in Paroxysmal Atrial Fibrillation Patients